Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001385508-21-000121
Filing Date
2021-09-01
Accepted
2021-09-01 16:04:41
Documents
1
Period of Report
2021-08-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_163052652615695.html 4  
1 FORM 4 wf-form4_163052652615695.xml 4 3044
  Complete submission text file 0001385508-21-000121.txt   4662
Mailing Address 233 WILSHIRE BLVD, SUITE 280 SUITE 500 SANTA MONICA CA 90401
Business Address 233 WILSHIRE BLVD, SUITE 280 SUITE 500 SANTA MONICA CA 90401 (310) 598-5410
OPIANT PHARMACEUTICALS, INC. (Issuer) CIK: 0001385508 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 233 WILSHIRE BLVD. SUITE 280 SANTA MONICA CA 90401
Business Address
Ruth Matthew R. (Reporting) CIK: 0001872022 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38193 | Film No.: 211230093